Neuralink Phase 3 Human Trials: Motor Cortex Interface

Elon Musk's neurotechnology company, Neuralink, has officially commenced Phase 3 human trials for its next-generation brain-computer interface. The latest N1 implant focuses on a high-density electrode array targeting the primary motor cortex with unprecedented resolution. Initial trial patients are demonstrating the ability to control complex digital interfaces simply by visualizing motor actions.

The most striking result from the early Phase 3 data is the neural typing speed, with patients achieving over 90 words per minute—approaching the speed of physical typing. The FDA is closely monitoring the trials as Neuralink pushes to commercialize the device for individuals with severe spinal cord injuries, potentially restoring their digital autonomy.